NCT02156908View on ClinicalTrials.gov

D-serine and Cognitive Remediation in Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Schizophrenia
Interventions
DRUG

D-serine

D-serine 60 mg/kg

Trial Locations (1)

10962

Nathan Kline Institute, Orangeburg

All Listed Sponsors
lead

Nathan Kline Institute for Psychiatric Research

OTHER

NCT02156908 - D-serine and Cognitive Remediation in Schizophrenia | Biotech Hunter | Biotech Hunter